256 related articles for article (PubMed ID: 2459874)
1. Serum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosis.
Vahlquist C; Selinus I; Vessby B
Acta Derm Venereol; 1988; 68(4):300-5. PubMed ID: 2459874
[TBL] [Abstract][Full Text] [Related]
2. Intra-epidermal accumulation of polymorphonuclear leukocytes in persistent palmoplantar pustulosis during treatment with acitretin.
van de Kerkhof PC; Chang A; van Dooren-Greebe R; Geiger JM; Happle R
Acta Derm Venereol; 1988; 68(6):499-503. PubMed ID: 2467488
[TBL] [Abstract][Full Text] [Related]
3. Pustulosis palmo-plantaris. Clinical and histological changes during etretin (acitretin) therapy.
Schröder K; Zaun H; Holzmann H; Altmeyer P; el-Gammal S
Acta Derm Venereol Suppl (Stockh); 1989; 146():111-6. PubMed ID: 2532841
[TBL] [Abstract][Full Text] [Related]
4. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
[TBL] [Abstract][Full Text] [Related]
5. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial.
Lassus A; Geiger JM
Br J Dermatol; 1988 Dec; 119(6):755-9. PubMed ID: 2974306
[TBL] [Abstract][Full Text] [Related]
6. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
[TBL] [Abstract][Full Text] [Related]
7. Plasma fat elimination tissue lipoprotein lipase activity and plasma fatty acid composition during sequential treatment with etretinate and isotretinoin.
Vahlquist C; Lithell H; Michaëlsson G; Selinus I; Vahlquist A; Vessby B
Acta Derm Venereol; 1987; 67(2):139-44. PubMed ID: 2438878
[TBL] [Abstract][Full Text] [Related]
8. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
Bjerke JR; Geiger JM
Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
Gollnick H; Rinck G; Bitterling T; Orfanos CE
Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
[TBL] [Abstract][Full Text] [Related]
10. [Changes in serum lipid fractions as a side effect of oral retinoids].
Gollnick H; Luley C; Schwartzkopff W; Orfanos CE
Z Hautkr; 1982 Sep; 57(17):1255-67. PubMed ID: 6216675
[TBL] [Abstract][Full Text] [Related]
11. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
Kingston TP; Matt LH; Lowe NJ
Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451
[TBL] [Abstract][Full Text] [Related]
12. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
13. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
Lacourcière Y; Gagné C
J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
[TBL] [Abstract][Full Text] [Related]
14. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
[TBL] [Abstract][Full Text] [Related]
15. Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies.
Geiger JM; Czarnetzki BM
Dermatologica; 1988; 176(4):182-90. PubMed ID: 2967779
[TBL] [Abstract][Full Text] [Related]
16. Acitretin treatment of severe psoriasis.
Török L; Kádár L; Geiger JM
Acta Derm Venereol Suppl (Stockh); 1989; 146():104-6. PubMed ID: 2532840
[TBL] [Abstract][Full Text] [Related]
17. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
Angquist KA; Johnson O; Ericsson M; Tollin C
Acta Chir Scand; 1982; 148(8):675-8. PubMed ID: 6820598
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of acitretin in the treatment of cutaneous lupus erythematosus.
Ruzicka T; Meurer M; Bieber T
Arch Dermatol; 1988 Jun; 124(6):897-902. PubMed ID: 2967674
[TBL] [Abstract][Full Text] [Related]
19. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
Meffert H; Sönnichsen N
Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
[No Abstract] [Full Text] [Related]
20. Side-effect profile of acitretin therapy in psoriasis.
Gupta AK; Goldfarb MT; Ellis CN; Voorhees JJ
J Am Acad Dermatol; 1989 Jun; 20(6):1088-93. PubMed ID: 2526824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
